ABL1 and acute lymphoblastic leukemia: Leukemic B-cell progenitors derived from BCR-ABL+ B-ALL patients showed enhanced aPKCι expression in comparison to healthy donor bone marrow (BM) derived B-cell progenitors (Supplementary Figure 1D).